Gapping up
News:
- CODI +12.3% (entered into a third forbearance agreement)
- FORD +11.3% (disclosed waiver with certain holders that extends the deadline to file the initial resale registration statement to the 60th calendar day following the Closing Date)
- RCUS +7.6% (reports Anti-TIGIT Domvanalimab plus Anti-PD-1 Zimberelimab and Chemotherapy showed 26.7 months of Median Overall Survival as first-line treatment of unresectable or advanced gastroesophageal adenocarcinomas in the Phase 2 EDGE-Gastric Study)
- MOB +6.1% (announces the launch of its Secured Autonomy Framework, which to the Company's knowledge is, the industry's first comprehensive cybersecurity platform for autonomous systems)
- SPAI +5.6% (files for $100 mln mixed securities shelf offering)
- RZLV +5.5% (announces shareholder transfer to a new global institutional investor)
- ALM +5.3% (commences legal proceedings against Pure Tungsten Inc. resulting from false and misleading statements)
- KOPN +4.3% (files appeal of the $19.7 mln judgement against the company in the matter of Blue Radios Inc. v. Kopin)
- DVLT +4.2% (announces the signing of a letter of intent to acquire NYIAX Inc., a technology and services company with operations in the U.S., Europe, and Dubai)
- NB +3.9% (files mixed securities shelf offering)
- HCM +3.7% (highlights FRUSICA-2 registration trial data to be presented at the 2025 ESMO Congress)
- FFAI +3.7% (shares weekly investor update) EU +3.6% (files for $350 mln mixed securities shelf offering)
- MRX +3.6% (reports CEO share purchases)
- VRT +3.5% (appoints Craig Chamberlin as CFO)
- CGEM +3.4% (Cullinan Therapeutics and Taiho Oncology present data on Zipalertinib in patients with NSCLC with EGFR mutations and active brain metastases at the ESMO Congress 2025)
- SPPP +3.3% (updates its "At-the-Market" equity program)
- GLXY +3% (announces $460 million strategic investment from a leading asset management firm)
- DNOW +3% (announced its future leadership team effective upon the completion of the pending transaction with MRC Global (MRC))
- PGEN +2.9% (reports long-term follow-up results highlighting ongoing durable complete responses after treatment with PAPZIMEOS)
- NPO +2.8% (enters into separate, definitive agreements to acquire two strategic assets in key growth areas within its Sealing Technologies segment, AlpHa Measurement Solutions and Overlook Industries for an aggregate of approximately $280 million in cash)
- MCHP +2.7% (unveils first 3 nm PCIe Gen 6 Switch to power modern AI infrastructure)
- CGEN +2.7% (to present pooled analysis of COM701 in three Phase 1 Trials in patients with platinum resistant ovarian cancer at ESMO 2025)
- KDK +2.3% (files for 184,793,179 share common stock offering by selling shareholders, relates to preferred share conversions and warrants)
- PLTR +2.2% (report that Govini, a defense tech software startup, has blown past $100 mln in ARR, according to CNBC)
- TSLA +2.1% (Shanghai gigafactory starts increasing production for Q4, according to Reuters; CyberTruck sales are falling, according to Business Insider)
- USAU +1.9% (provided Cantor with notice of termination of the Sales Agreement with such termination to be effective October 20, 2025)
- CAT +1.7% (enters agreement to acquire RPMGlobal)
- USGO +1.7% (completes 2025 exploration program at the Whistler Gold-Copper Project)
- SLS +1.6% (files for 19,685,040 share common stock offering by selling shareholders)
- ONC +1.5% (receives FDA Breakthrough Therapy Designation for Sonrotoclax)
- BEDU +1.4% (to go private in $2.30-Per-ADS merger deal backed by management-led buyer group)